Bird Flu / Avian Flu News From Medical News TodayLatest Bird Flu / Avian Flu News From Medical News Today.ECRI Institute And IAHSS Offer Guidance On Preparing For Pandemic Flu - July 17 Web Conference- June 26, 2008 Plans for appropriate respiratory protection are a major part of healthcare facilities' pandemic preparation. To assist hospitals with the complex task of protecting frontline staff in the event of an outbreak, ECRI Institute and the International Association for Healthcare Safety and Security (IAHSS) presenthttp://www.medicalnewstoday.com/articles/112838.php West Nile Virus Threat Reduced By Diversity Among Bird Populations In Surrounding Area- June 26, 2008 A more diverse bird population can help lower the incidence of West Nile virus in the surrounding human population, in a process called the "dilution effect," according to an article released in the open access journal PLoS ONE on June 25, 2008. West Nile Virus, usually infecting birds but also affecting humans, is often passed through mosquitoes.http://www.medicalnewstoday.com/articles/112270.php Biotech Experts Available To Discuss The Critical Role Of Vaccine Adjuvants In Treating Pandemic Bird Flu- June 19, 2008 The likelihood of an influenza pandemic caused by an avian influenza (Bird Flu) virus is an increasing concern to the World Health Organization (WHO) and others. Recent breakthroughs on promising cell-based vaccines are encouraging, but manufacturing, stockpiling and distributing enough vaccine to treat victims on a massive scale remain a challenge that needs attention.http://www.medicalnewstoday.com/articles/111786.php New Study Demonstrates That Lack Of Pandemic Planning Will Affect Bottom Line- June 18, 2008 The Schulich School of Business released the first study to assess the impact of an influenza pandemic on individual companies. Presented today at the World Conference on Disaster Management, the study - Making a case for investing in pandemic preparedness - focuses on how companies can justify investing in pandemic planning using standard business performance metrics.http://www.medicalnewstoday.com/articles/111741.php Sanofi Pasteur To Donate 60 Million Doses Of H5N1 Vaccine To WHO Over 3 Years For Its Influenza Vaccine Global Stockpile- June 17, 2008 Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced yesterday its commitment to donate 60 million doses of H5N1 vaccine to the World Health Organization (WHO) over 3 years for the establishment of an H5N1 vaccine global stockpile. "The H5N1 virus is currently circulating in some of the poorest regions of the world and an outbreak of pandemic influenza would most likely hit populations living in areas with limited access to vaccines.http://www.medicalnewstoday.com/articles/111461.php No High Risk Avian Influenza Viruses Found In Canada's Wild Birds- June 13, 2008 The Government of Canada is committed to preventing the introduction of avian influenza in Canada's domestic poultry flocks. Canada's 2007 Interagency Wild Bird Influenza Survey confirmed no findings of highly pathogenic avian influenza in Canada's wild bird population.http://www.medicalnewstoday.com/articles/111160.php CDC Finds Some Bird Flu Strains Have Acquired Properties That Might Enhance Potential To Infect Humans- June 12, 2008 The Centers for Disease Control and Prevention (CDC) recently released results of a study suggesting that some North American avian influenza A H7 virus strains have properties that might enhance their potential to infect humans as well as their potential to spread from human to human. The study was recently published in the Proceedings of the National Academy of Sciences USA. Avian influenza A H7 viruses are fairly common in birds, but rarely infect humans.http://www.medicalnewstoday.com/articles/110980.php H7 Bird Flu Increasing Potential To Infect And Spread Among Humans Reports CDC- June 12, 2008 A type of avian flu that is common in birds and rarely caught by humans, the North American Avian H7 influenza virus, is acquiring transmission properties similar to human influenza, according to a new study by US researchers at the Centers for Disease Control and Prevention (CDC), based in Atlanta.http://www.medicalnewstoday.com/articles/111063.php New England Journal Of Medicine Publishes Study Investigating Safety And Efficacy Of Baxter's Cell-Based Pandemic, Avian Flu Vaccine- June 12, 2008 Baxter International Inc. (NYSE: BAX) announced publication in the June 12, 2008 issue of The New England Journal of Medicine (NEJM) of data demonstrating Baxter's candidate avian influenza (H5N1) vaccine, CELVAPAN, met Phase III trial endpoints for safety and immunogenicity (generating a functional immune response).http://www.medicalnewstoday.com/articles/110931.php |